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Abstract
Background: Sri Lanka was the first country in the Southeast Asian region to achieve its measles elimination goal
in 2011. In 2012, the measles immunization schedule changed from a measles vaccine at 9 months to a measles,
mumps and rubella vaccine at 12 months. However in 2013, Sri Lanka reported its worst recent outbreak of measles.
This study investigated a part of this outbreak in order to describe its epidemiology.
Methods: A prospective study was carried out at the university medical unit of the Teaching Hospital, Anuradhapura
(THA), the third largest hospital in Sri Lanka, from October 2013 until March 2014. An epidemiological profile of patients
was constructed, case confirmation was done on all suspected cases and the basic demographic details of these
suspected cases were obtained from the available records.
Results: From January 2013 to March 2014, 101 measles suspects were admitted to the THA. Until June 2013, all
suspected cases were aged below 12 months of age. During the study period (15 months), the total number of
patients aged below 9 months, 9 to 12 months, 1 to 11 years, 12–29 years and over 29 years were 10 (9.9 %), 11
(10.9 %), 6 (5.9 %), 37 (36.6 %) and 36 (35.6 %), respectively (data missing-1). Out of the 33 patients clinically
suspected, 32 tested positive for measles. Common clinical features included: fever (n = 33, 100 %), maculopapular rash
(n = 33), conjunctivitis (n = 31), posterior cervical lymphadenopathy (n = 23) and Koplik’s spots (n = 8). Features suggestive
of pneumonia were observed among 30 (90.9 %) patients and 26 (78.8 %) had diarrhoea. Two patients (6.1 %)
who developed severe pneumonia received care at an intensive care unit due to respiratory difficulties. Out of 33
patients, 15 (45.5 %) had prior immunization for measles, two (6.1 %) reported that they never had a measles
immunization and 16 (48.5 %) were unsure about their immunization status. Out of those who reported they
were previously immunized, 11 (73.3 %) belonged to the age group of 12–29 years.
Conclusion: Because the first cases of this outbreak were infants, an increase in susceptible infants due to the
change in the vaccine schedule could partly explain the outbreak.
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Background
Measles is one of the most contagious human diseases.
Before the introduction of measles-containing vaccines
(MCVs), 90 % of children had measles during the first
15 years of their lives. In 1980, the global number of
deaths attributed to measles was exceeding 2.5 million
[1]. The first MCV was licensed in the USA in 1963
based on the pioneering work of Enders [2, 3]. This vac-
cine has since become one of the most effective inter-
ventions that mankind has ever invented [4].
After the successful eradication of small pox, measles
elimination was the number one priority in vaccine pre-
ventable disease control programmes worldwide. A
steady increase of MCV coverage and the subsequent
decline of measles incidence has been observed globally
over the past two decades [5]. In 2008, however, there
was a worldwide resurgence of measles, mainly affecting
28 Sub-Saharan African countries [6–10]. More than
200,000 cases and more than 1400 deaths were reported
during this outbreak [11].
Sri Lanka’s measles control programme has achieved
many of its goals since setting its measles elimination
targets in 1984. The annual incidence of measles in the
country between 1971 and 1980 varied from 12 to 49
per 100,000 population. In August 1984, the measles
vaccine was introduced into the expanded programme
on immunization (EPI). After this, several local out-
breaks of measles [12] were observed, but the annual in-
cidence of measles declined, up until 1999. A measles
epidemic then hit, lasting from October 1999 to June
2000; more than 15,000 cases and five deaths were re-
ported. Nearly 54 % of the cases were ≥15 years of age
at the time of disease onset. The highest morbidity was
observed in the age group of <9 months (114 cases per
100,000 population), followed by the 15–19 age group
(87 per 100,000 population) [13]. After the 1999–2000
measles outbreak, a two-dose schedule of the measles
vaccination was introduced into the EPI. There has been
a decline in annual measles incidence since then, reach-
ing the elimination target of <5 per million population
in 2011.
In the second quarter of 2013, however, Sri Lanka
experienced another island-wide measles outbreak. It
started in Colombo, soon spreading all over the country.
Even though this outbreak was the second largest the
country has seen in 20 years, scientific research to de-
scribe this outbreak is scarce. The purpose of this study
is to describe the epidemiology of the 2013 measles out-
break in Sri Lanka.
Methods
Study site and design
To describe the spatio-temporal distribution of measles,
we used secondary data on measles patients admitted to
the Teaching Hospital, Anuradhapura (THA). The THA
is the third' largest hospital in Sri Lanka and the main
referral hospital in the Anuradhapura district. It has
three medical and three paediatric units. At the THA,
infectious control nurses are responsible for the surveil-
lance of communicable diseases. They collect basic
information from all inpatients with suspected commu-
nicable diseases.
A descriptive cross-sectional study was carried out on
suspected measles patients admitted to the university
medical unit (UMU) at the THA from October 2013, in
order to describe their clinical and bio-chemical profiles
and complications. Inclusion criteria were based on the
clinician’s diagnosis. If the treating physician tentatively
diagnosed measles in a patient, he/she was included in
the study.
Data collection
Following the tentative diagnosis, 3 ml of venous blood
was obtained and sent to the Medical Research Institute
(MRI) of Sri Lanka for disease confirmation, using the
measles IgM enzyme-linked immunosorbent assay
(ELISA) test. On admission, suspected measles cases
underwent clinical examination by two investigators to
document the patients’ positive and negative clinical fea-
tures. The patients were then followed up until they were
discharged from hospital. Because measles is a vaccine-
preventable disease, special case report forms are available
to be used by health professionals for disease investigation.
We used these interviewer-administered forms to collect
patients’ basic socio-demographic data. All clinical data
were carefully documented using a clinical data checklist
under the supervision of the treating physician. Details on
blood biochemistry of the patients were extracted from
the patient’s records (bed-head tickets).
Data analysis
Only descriptive analysis was performed using percentages
and proportions.
Ethical clearance
Informed consent was obtained from all eligible patients
prior to commencement of the study. Ethical clearance
for the study was obtained from the Ethics Review Com-
mittee of the Faculty of Medicine and Allied Sciences,
Rajarata University of Sri Lanka.
Results
One hundred and one patients with suspected measles
were admitted to the THA within the 15-month period
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between January 2013 and March 2014. The total num-
bers of patients aged below 9 months, 9 to 12 months, 1
to 11 years, 12–29 years and over 29 years were 10
(9.9 %), 11 (10.9 %), 6 (5.9 %), 37 (36.6 %) and 36
(35.6 %), respectively (age was missing in one patient ad-
mitted to paediatric ward). Of the total participants, 52
(51.5 %) were males. There were no suspected measles
patients admitted during the first two months of 2013
(see Fig. 1). There was one admission each in the follow-
ing 4 months, all of whom were in the 9 to 12 months
age group.
A clinical study with case confirmation was carried
out in the UMU. A total of 33 patients with suspected
measles were admitted to the unit, from the last week of
October 2013 to the end of March 2014. Serum samples
from 32 patients were sent to the MRI for disease con-
firmation and all 32 (100 %) tested positive for IgM mea-
sles antibodies.
The mean age was 27.64 ± 7.38 and the youngest
patient was 16 (admission to the UMU were patients
older than 13 years). Out of the 33 patients, 21 (63.6 %)
were males.
All patients had fever on admission (see Table 1).
Maculopapular rash was observed in 27 patients on ad-
mission. We specifically looked for typical Koplik’s spots;
it was observed in eight patients. Two patients (6.1 %)
who developed severe pneumonia received care at an in-
tensive care unit (ICU) due to respiratory difficulties.
Both of them had bi-lateral patchy opacifications in the
chest radiograph and received non-invasive positive
pressure ventilation together with broad-spectrum anti-
biotics. The first patient had a dramatic recovery within
24 h, but the second patient was in the ICU for 72 h.
All but two patients had normal white cell count
(WCC) (see Table 2). A differential count revealed neu-
trophils predominance in all patients. The mean platelet
count was 159 ± 50.2 × 103/μL and 17 patients had a
platelet count of less than 150 × 103/μL.
A late presentation to hospital among patients was
observed and the median duration of fever on admission
was 5 days (IQR: 4 to 7 days). The total duration of ill-
ness (onset of the first symptom until discharge) ranged
from 5 to 16 days, with a median of 8 days. The median
duration of hospital stay was 4 days (range: 2 to 7 days).
Out of the 33 patients admitted to the UMU THA, 15
(45.5 %) had prior immunization for measles, two
(6.1 %) reported that they never had a measles
immunization and 16 (48.5 %) were unsure about their
immunization status. Out of those who reported that
they were previously immunized, 11 (73.3 %) belonged
to age group of 12–29 years. Five patients gave a contact
history of measles over the last 4 weeks and two re-
ported that a family member had fever and rash. Only
one patient said he/she lived in a semi-permanent struc-
ture with poor hygiene and sanitary conditions.
Discussion
In this study, we investigated a part of Sri Lanka’s most
recent measles outbreak. The study showed that the first
wave of patients during this outbreak in Anuradhapura
comprised infants aged below 12 months. Furthermore,
our detailed investigation of adult patients revealed that
the majority showed signs of developing severe compli-
cations such as pneumonia, with a few requiring inten-
sive care.
As part of the measles elimination programme, a
MCV was introduced into Sri Lanka’s EPI in 1984 as a
single-dose vaccine administered to infants aged
9 months. Therefore, individuals aged 29 years or above
have not had a routine vaccination for measles. Most of
the individuals in the 11–29 age group only had a single
dose of the MCV, as the guideline for a second dose was
Fig. 1 Temporal distribution of suspected measles cases admitted to the THA from January 2013 to March 2014, by age group
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only added to the EPI schedule (measles-rubella vaccine
at 3 years) in 2002, following the island-wide measles
outbreak of 1999–2000. In 2012, the EPI schedule was
revised again, with the introduction of the measles,
mumps and rubella vaccine to be administered to babies
aged 12 months.
The 2013 outbreak of measles in Anuradhapura (and
probably in Sri Lanka) could be due to several reasons.
A non-immune cohort of people, born prior to 1984,
who have never been properly vaccinated or had the nat-
ural infection were probably the base population for this
outbreak. Another group of susceptible people are those
who received a single dose of MCV between 1984 and
2000 and missed the booster dose in supplementary pro-
grammes. Based on previous data, the proper antibody
response could not have happened in 15 % of the people
who received only a single dose of the MCV [14].
Among those who received two doses, a decrease in vac-
cine effectiveness may have contributed to this outbreak.
In the initial phase of the outbreak, mainly infants
were affected. This could be attributed to several factors.
Recent studies have shown that babies born to mothers
who were immune from measles due to vaccination ra-
ther than natural infection are more susceptible to infec-
tion unless they are immunized early. This is due to
babies’ relatively low antibody level (or short period of
passive immunity) that has transferred from the mother’s
immunity due to being vaccinated [15, 16]. Most import-
antly, however, is the question of whether the shift of
the first dose of MCV being administered at 9 months
of age to 12 months had a significant effect on the
current outbreak. Typically, transferred immunity from
mother to baby starts to wane around the age of 5 to
9 months. If mothers have vaccine-derived immunity,
waning starts much earlier [17]. Recent studies also
point to early susceptibility to measles in infants of both
vaccinated women and women with naturally acquired
immunity [18]. In Sri Lanka, the mean age of women at
childbirth is around 28 years. At the time of this out-
break, some mothers in this age group may not have
ever had measles and therefore transferred the antibody
to their babies; around 50 % might have had vaccine-
derived immunity. Even among vaccinated women, anti-
body levels could be low [19]. Either way, infants born
to these mothers are more susceptible to measles in
early infancy. Even though vaccine effectiveness is 95 %
when administered at the age of 12 months [20], the
chances of getting measles could be reduced by giving
the vaccine at the age of 9 months, as this is around the
age when risk of mortality is higher. Cost benefits and
health outcomes would be much better if the first dose
of MCV was administered at 9 months, even though its
effectiveness rate is lower (85 %) [21]. The change in the
vaccine schedule means that infants are now susceptible
to measles. It could have been the triggering factor for
this outbreak, as it could have increased the cohort of
susceptible population up to the threshold level for the
outbreak.
Measles can be associated with complications such as
pneumonia, otitis media, encephalitis, diarrhoea and rare
long-term sequel subacute sclerosing pan encephalitis.
Table 2 Blood and urine biochemistry of the 33 measles
patients admitted to the UMU THA, 2013–14
Mean ± SD
Haemoglobin (mg/dL) 13.4 ± 1.3
WCC (103/mm3) 6.1 ± 2.1
WCC range (103/μL) 2.3–13.3
Neutrophil (%) 80.7 ± 6.9
Neutrophil range (%) 61–94 %
Lymphocytes (%) 12.8 ± 6.2
Platelet count (103/ μL) 159 ± 50.2
Platelet count (<150 × 103/ μL) 17(51.5 %)
SGOT (IU/L) 138.1 ± 81.2
SGOT range (IU/L) 48–326
SGPT (IU/L) 137.6 ± 91.5
SGPT range (IU/L) 42–316
ESR (mm in first hour) 18.8 ± 9.1
CRP 26.8 ± 20.2
Proteinuria 12(36.3)
WCC white cell count, SGOT serum glutamic oxaloacetic transaminase, SGPT
serum glutamic-pyruvic transaminase, ESR erythrocyte sedimentation rate, CRP
C-reactive protein
Table 1 Clinical profile of 33 measles patients admitted to the
UMU THA, 2013–14
Clinical features N(%)
Fever on admission 33(100)
Rash on admission 27(81.8)
Rash developed after admission 6(18.2)
Generalized rash 31(93.9)
First appearance of rash
Face 17(51.5)
Trunk 14(42.4)





Posterior cervical lymphadenopathy 23(69.7)
Features of pneumonia 30(90.9)
Hepatomegaly 14(42.4)
Koplik’s spots 8(24.2)
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During the 1999–2000 outbreak, only 2.2 % of patients
had features suggestive of pneumonia. Meanwhile, diar-
rhoea, otitis media and encephalitis were noted in 16.7,
1.4 and 0.5 % of patients, respectively. Neurological
complications of measles during this outbreak were well
documented [22]. There were five measles-related
deaths, however, their actual causes were not docu-
mented. Among the 33 patients admitted to the UMU
THA, 30 (90.9 %) and 26 (78.8 %) had pneumonia and
diarrhoea, respectively. Other complications were not
observed, but two patients became tachypnoeic and hyp-
oxic and required ICU care. Most of the measles pa-
tients admitted to the UMU had a normal WCC,
thrombocytopenia and elevated liver transaminases,
which can also be noted in dengue fever, Rickettsial in-
fections, atypical pneumonia and sometimes leptospir-
osis, all of which are common in Sri Lanka. Therefore, if
the rash goes unnoticed, especially in dark-skinned indi-
viduals, measles can be mistakenly treated as one of the
above conditions.
Conclusion
In developing countries such as Sri Lanka, better health
indicators have been developed due to exceptional public
health programmes such as the current immunization
programme. However, these indicators aren’t necessarily
related with an improvement in the socio-economic
status, as poverty, poor hygiene, overcrowded environ-
ments and other risk factors for communicable disease
transmission exist in these countries. This may be the pri-
mary reason for communicable disease outbreaks in de-
veloping countries, even those triggered by minor factors.
According to the analysis of data from the THA, the trig-
gering factor for this outbreak may have been the change
in the immunization schedule in 2012. However, it is
essential to investigate national data from Sri Lanka to
arrive at a final conclusion. This information may be ex-
tremely important on a global scale for future decision-
making, in order to eradicate measles once and for all.
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